Octagon Capital Advisors LP Quant / Systematic

CIK: 0001839435 · Show all filings

Period: Q4 2020 (Next →)

Filing Date: Feb 16, 2021

Total Value ($000): $288,474 (100.0% shares, 0.0% debt)

Holdings (31)

APLS APELLIS PHARMACEUTICALS INC 10.9%

Value ($000) $31,367 Shares 548,374 Est. Cost $42.30 Unrealized 0.0%

Value ($000) $21,432 Shares 454,550 Est. Cost $47.15 Unrealized —

CLDX CELLDEX THERAPEUTICS INC NEW 6.3%

Value ($000) $18,245 Shares 1,041,398 Est. Cost $18.00 Unrealized 0.0%

— CURIS INC 6.2%

Value ($000) $18,018 Shares 2,200,000 Est. Cost $8.19 Unrealized —

FDMT 4D MOLECULAR THERAPEUTICS IN 5.4%

Value ($000) $15,659 Shares 377,777 Est. Cost $41.28 Unrealized 0.0%

PMVP PMV PHARMACEUTICALS INC 5.3%

Value ($000) $15,378 Shares 250,000 Est. Cost $39.23 Unrealized 0.0%

ARVN ARVINAS INC 5.3%

Value ($000) $15,160 Shares 178,500 Est. Cost $34.48 Unrealized 0.0%

GOSS GOSSAMER BIO INC 5.2%

Value ($000) $15,116 Shares 1,563,138 Est. Cost $9.85 Unrealized 0.0%

— ACCELERON PHARMA INC 5.0%

Value ($000) $14,376 Shares 112,363 Est. Cost $127.94 Unrealized —

— CHEMOCENTRYX INC 4.8%

Value ($000) $13,937 Shares 225,076 Est. Cost $61.92 Unrealized —

CRDF CARDIFF ONCOLOGY INC 4.1%

Value ($000) $11,694 Shares 650,000 Est. Cost $17.58 Unrealized 0.0%

RNAM AVIDITY BIOSCIENCES INC 3.8%

Value ($000) $10,975 Shares 430,041 Est. Cost $29.16 Unrealized 0.0%

DYN DYNE THERAPEUTICS INC 3.5%

Value ($000) $10,112 Shares 481,538 Est. Cost $19.78 Unrealized 0.0%

TSHA TAYSHA GENE THERAPIES INC 2.9%

Value ($000) $8,504 Shares 320,440 Est. Cost $21.54 Unrealized 0.0%

RCUS ARCUS BIOSCIENCES INC 2.7%

Value ($000) $7,788 Shares 300,000 Est. Cost $24.20 Unrealized 0.0%

— CALLIDITAS THERAPEUTICS AB 2.3%

Value ($000) $6,724 Shares 200,000 Est. Cost $33.62 Unrealized —

— FIBROGEN INC 1.9%

Value ($000) $5,416 Shares 146,014 Est. Cost $37.09 Unrealized —

— KINIKSA PHARMACEUTICALS LTD 1.8%

Value ($000) $5,217 Shares 295,238 Est. Cost $17.67 Unrealized —

RVMD REVOLUTION MEDICINES INC 1.7%

Value ($000) $4,994 Shares 126,136 Est. Cost $39.54 Unrealized 0.0%

KURA KURA ONCOLOGY INC 1.7%

Value ($000) $4,899 Shares 150,000 Est. Cost $35.14 Unrealized 0.0%

— IVERIC BIO INC 1.6%

Value ($000) $4,699 Shares 680,036 Est. Cost $6.91 Unrealized —

MLTX HELIX ACQUISITION CORP 1.6%

Value ($000) $4,548 Shares 400,000 Est. Cost $11.37 Unrealized —

— KRONOS BIO INC 1.5%

Value ($000) $4,366 Shares 146,173 Est. Cost $29.87 Unrealized —

— JIYA ACQUISITION CORP 1.1%

Value ($000) $3,090 Shares 300,000 Est. Cost $10.30 Unrealized —

— VIELA BIO INC 1.1%

Value ($000) $3,072 Shares 85,409 Est. Cost $35.97 Unrealized —

IVA INVENTIVA SA 1.0%

Value ($000) $2,900 Shares 200,000 Est. Cost $14.50 Unrealized —

ARQT ARCUTIS BIOTHERAPEUTICS INC 1.0%

Value ($000) $2,813 Shares 100,000 Est. Cost $24.49 Unrealized 0.0%

— NGM BIOPHARMACEUTICALS INC 0.8%

Value ($000) $2,279 Shares 75,227 Est. Cost $30.29 Unrealized —

ACRS ACLARIS THERAPEUTICS INC 0.8%

Value ($000) $2,265 Shares 350,000 Est. Cost $4.22 Unrealized 0.0%

— KADMON HLDGS INC 0.6%

Value ($000) $1,802 Shares 434,114 Est. Cost $4.15 Unrealized —

AXSM AXSOME THERAPEUTICS INC 0.6%

Value ($000) $1,629 Shares 20,000 Est. Cost $74.78 Unrealized 0.0%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
APLS	APELLIS PHARMACEUTICALS INC	548,374	$31,367	10.9%	$42.30	0.0%	COM	03753U106
NBP	I MAB	454,550	$21,432	7.4%	$47.15	—	SPONSORED ADS	44975P103
CLDX	CELLDEX THERAPEUTICS INC NEW	1,041,398	$18,245	6.3%	$18.00	0.0%	COM NEW	15117B202
—	CURIS INC	2,200,000	$18,018	6.2%	$8.19	—	COM NEW	231269200
FDMT	4D MOLECULAR THERAPEUTICS IN	377,777	$15,659	5.4%	$41.28	0.0%	COM	35104E100
PMVP	PMV PHARMACEUTICALS INC	250,000	$15,378	5.3%	$39.23	0.0%	COM	69353Y103
ARVN	ARVINAS INC	178,500	$15,160	5.3%	$34.48	0.0%	COM	04335A105
GOSS	GOSSAMER BIO INC	1,563,138	$15,116	5.2%	$9.85	0.0%	COM	38341P102
—	ACCELERON PHARMA INC	112,363	$14,376	5.0%	$127.94	—	COM	00434H108
—	CHEMOCENTRYX INC	225,076	$13,937	4.8%	$61.92	—	COM	16383L106
CRDF	CARDIFF ONCOLOGY INC	650,000	$11,694	4.1%	$17.58	0.0%	COM	14147L108
RNAM	AVIDITY BIOSCIENCES INC	430,041	$10,975	3.8%	$29.16	0.0%	COM	05370A108
DYN	DYNE THERAPEUTICS INC	481,538	$10,112	3.5%	$19.78	0.0%	COM	26818M108
TSHA	TAYSHA GENE THERAPIES INC	320,440	$8,504	2.9%	$21.54	0.0%	COM SHS	877619106
RCUS	ARCUS BIOSCIENCES INC	300,000	$7,788	2.7%	$24.20	0.0%	COM	03969F109
—	CALLIDITAS THERAPEUTICS AB	200,000	$6,724	2.3%	$33.62	—	SPONSERED ADS	13124Q106
—	FIBROGEN INC	146,014	$5,416	1.9%	$37.09	—	COM	31572Q808
—	KINIKSA PHARMACEUTICALS LTD	295,238	$5,217	1.8%	$17.67	—	COM CL A	G5269C101
RVMD	REVOLUTION MEDICINES INC	126,136	$4,994	1.7%	$39.54	0.0%	COM	76155X100
KURA	KURA ONCOLOGY INC	150,000	$4,899	1.7%	$35.14	0.0%	COM	50127T109
—	IVERIC BIO INC	680,036	$4,699	1.6%	$6.91	—	COM	46583P102
MLTX	HELIX ACQUISITION CORP	400,000	$4,548	1.6%	$11.37	—	COM CL A	G4444C102
—	KRONOS BIO INC	146,173	$4,366	1.5%	$29.87	—	COM	50107A104
—	JIYA ACQUISITION CORP	300,000	$3,090	1.1%	$10.30	—	COM CL A	47760M102
—	VIELA BIO INC	85,409	$3,072	1.1%	$35.97	—	COM	926613100
IVA	INVENTIVA SA	200,000	$2,900	1.0%	$14.50	—	ADS	46124U107
ARQT	ARCUTIS BIOTHERAPEUTICS INC	100,000	$2,813	1.0%	$24.49	0.0%	COM	03969K108
—	NGM BIOPHARMACEUTICALS INC	75,227	$2,279	0.8%	$30.29	—	COM	62921N105
ACRS	ACLARIS THERAPEUTICS INC	350,000	$2,265	0.8%	$4.22	0.0%	COM	00461U105
—	KADMON HLDGS INC	434,114	$1,802	0.6%	$4.15	—	COM	48283N106
AXSM	AXSOME THERAPEUTICS INC	20,000	$1,629	0.6%	$74.78	0.0%	COM	05464T104